Skip to main content
Clinical Trials/CTRI/2023/04/051890
CTRI/2023/04/051890
Not yet recruiting
Phase 4

A COMPARATIVE STUDY OF EFFECTIVENESS OF PROPOFOL, KETOFOL AND KETOFOL WITH DEXMEDETOMIDINE AS INDUCTION AGENT FOR ELECTROCONVULSIVE THERAPY

MGM MEDICAL COLLEGE AND HOSPITAL AURANGABAD0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: F323- Major depressive disorder, singleepisode, severe with psychotic featuresHealth Condition 2: F39- Unspecified mood [affective] disorder
Sponsor
MGM MEDICAL COLLEGE AND HOSPITAL AURANGABAD
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
MGM MEDICAL COLLEGE AND HOSPITAL AURANGABAD

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients with American society of Anaesthesiology (ASA) physical status I and II
  • 2\.Patients of both sexes between the ages of 18 and 65 years.

Exclusion Criteria

  • 1\.Patient on chronic opiate use such as tramadol
  • 2\.Pregnant females and lactating mothers.
  • 3\.Known allergies to the study drugs
  • 4\.Patients with hypertension, IHD and heart disease
  • 5\.Contraindications to ECT such as intracranial hypertension, previous fractures, glaucoma, cerebrovascular malformation, presence of a pacemaker.
  • 6 Patient on Beta\-blockers.

Outcomes

Primary Outcomes

Not specified

Similar Trials